2m 2m 2m 2m 2m 2m 2m
Varex Imaging (VREX)
NASDAQ
$10.54+$0.02 (+0.14%)
Price as of Jun 23, 2026 4:10 PM EDT- $438.3MMarket Cap
- 32.33%1-Year Change
- Medical DevicesIndustry
Varex Imaging (VREX)
$10.54+$0.02 (+0.14%)
Annual
Quarterly
10/03/2025 | 09/27/2024 | 09/29/2023 | 09/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 844.6M +4.14% | 811.0M -9.22% | 893.4M +3.96% | 859.4M +5.05% | |
Cost of Revenue | 554.1M 0.00% | 554.1M -8.12% | 603.1M +4.72% | 575.9M +5.36% | |
Gross Profit | 290.5M +13.08% | 256.9M -11.51% | 290.3M +2.40% | 283.5M +4.42% | |
Sales and Marketing Expense | 133.3M -3.27% | 137.8M +7.32% | 128.4M +8.54% | 118.3M -5.74% | |
Research and Development Expense | -91.1M +4.71% | -87.0M +2.59% | -84.8M +10.13% | -77.0M +7.09% | |
Depreciation and Amortization Expense | 4.0M -59.60% | 9.9M -27.74% | 13.7M -6.16% | 14.6M -13.10% | |
Total Operating Expenses | 318.3M +41.59% | 224.8M +5.44% | 213.2M +9.17% | 195.3M -1.06% | |
Operating Profit | -27.8M -186.60% | 32.1M -58.37% | 77.1M -12.59% | 88.2M +19.03% | |
Interest Income | 8.5M +16.44% | 7.3M +97.30% | 3.7M +825.00% | 400,000 +300.00% | |
Interest Expense | N/A N/A | N/A N/A | -29.3M -26.38% | -39.8M -5.46% | |
Interest Income and Expense and Net | 8.5M +16.44% | 7.3M +128.52% | -25.6M -35.03% | -39.4M -6.19% | |
Total Nonoperating Income and Expense | -31.4M +15.87% | -27.1M -40.83% | -45.8M +4.81% | -43.7M -3.96% | |
Income before Taxes | -59.2M -1,284.00% | 5.0M -84.03% | 31.3M -29.66% | 44.5M +55.59% | |
Income Taxes | 10.7M -79.50% | 52.2M +400.00% | -17.4M -227.01% | 13.7M +28.04% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -70.3M +47.38% | -47.7M -198.96% | 48.2M +59.08% | 30.3M +74.14% | |
Net Income from Continuing Operations Applicable to Common | -59.2M -1,284.00% | 5.0M -84.03% | 31.3M +3.30% | 30.3M +74.14% | |
Basic EPS and Net Income | -1.70 +45.30% | -1.17 -197.50% | 1.20 +57.89% | 0.76 +72.73% | |
Diluted EPS and Net Income | -1.70 +45.30% | -1.17 -208.33% | 1.08 +47.95% | 0.73 +69.77% | |
Basic Weighted Average Shares | 41.4M +1.47% | 40.8M +1.24% | 40.3M +1.26% | 39.8M +1.27% | |
Diluted Weighted Average Shares | 41.4M +1.47% | 40.8M -18.89% | 50.3M +20.91% | 41.6M +3.23% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 145.0M -14.05% | 168.7M +10.55% | 152.6M +70.69% | 89.4M -38.17% | |
Short-Term Investments | 10.1M -68.24% | 31.8M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 155.1M -22.64% | 200.5M +31.39% | 152.6M +70.69% | 89.4M -38.17% | |
Total Current Assets | 641.8M -1.25% | 649.9M -1.28% | 658.3M +7.94% | 609.9M +10.05% | |
Accumulated Depreciation | 271.0M +7.45% | 252.2M +5.30% | 239.5M +4.95% | 228.2M +6.34% | |
Property and Plant and Equipment and Net | 157.8M +2.87% | 153.4M +6.82% | 143.6M +1.63% | 141.3M +0.78% | |
Total Long-Term Assets | 38.6M -17.52% | 46.8M +24.80% | 37.5M -13.19% | 43.2M +32.52% | |
Total Assets | 1.1B -9.01% | 1.2B -2.61% | 1.2B +5.50% | 1.2B +3.22% | |
Income Taxes Payable | 5.5M +292.86% | 1.4M N/A | 0 -100.00% | 500,000 -77.27% | |
Total Short-Term Debt | 1.5M -96.76% | 46.3M +2,986.67% | 1.5M -28.57% | 2.1M -25.00% | |
Total Current Liabilities | 187.2M -4.44% | 195.9M +20.33% | 162.8M -5.95% | 173.1M +3.90% | |
Total Long-Term Debt | 366.0M -7.83% | 397.1M -9.98% | 441.1M +6.99% | 412.3M -4.49% | |
Total Long-Term Liabilities | 38.1M -24.40% | 50.4M +21.15% | 41.6M +23.08% | 33.8M +6.29% | |
Total Liabilities | 620.8M -7.04% | 667.8M -0.12% | 668.6M +4.85% | 637.7M -2.04% | |
Retained Earnings | -5.9M -108.38% | 70.4M -40.39% | 118.1M +85.11% | 63.8M +90.45% | |
Total Stockholders Equity | 472.6M -11.68% | 535.1M -5.74% | 567.7M +6.43% | 533.4M +10.37% | |
Total Shares Outstanding | 41.7M +1.45% | 41.1M +1.39% | 40.5M +1.11% | 40.1M +1.65% | |
Cash Flow | |||||
Cash from Operating Activities | 41.7M -11.84% | 47.3M -56.37% | 108.4M +541.42% | 16.9M -81.75% | |
Capital Expenditures | 22.9M -14.87% | 26.9M +29.95% | 20.7M -2.82% | 21.3M +41.06% | |
Cash from Investing Activities | 10.3M +137.45% | -27.5M -38.75% | -44.9M -7.23% | -48.4M +198.77% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -75.9M +2,200.00% | -3.3M +1,550.00% | -200,000 -99.16% | -23.8M -26.32% | |
Financials Ratio | |||||
Gross Margin | 34.40% +8.58% | 31.68% -2.51% | 32.49% -1.50% | 32.99% -0.60% | |
Operating Margin | -3.29% -183.16% | 3.96% -54.14% | 8.63% -15.91% | 10.26% +13.31% | |
Return on Assets | -6.05% +56.40% | -3.87% -197.65% | 3.96% +52.41% | 2.60% +70.79% | |
Return on Equity | -13.95% +61.29% | -8.65% -198.81% | 8.75% +46.88% | 5.96% +60.15% | |
Revenue Growth | 4.14% +144.92% | -9.22% -333.13% | 3.96% -21.63% | 5.05% -53.29% | |
Current Ratio | 3.43 +3.34% | 3.32 -17.96% | 4.04 +14.76% | 3.52 +5.92% | |
Cash Ratio | 0.77 -10.06% | 0.86 -8.12% | 0.94 +81.47% | 0.52 -40.49% | |
Debt-to-Equity Ratio | 0.78 -6.15% | 0.83 +6.29% | 0.78 +0.35% | 0.78 -13.58% | |
Debt-to-Assets Ratio | 0.33 -8.89% | 0.36 +2.85% | 0.35 +1.23% | 0.35 -7.58% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow